Novartis AG ADR (NVS)vsOwlet Inc (OWLT)
NVS
Novartis AG ADR
$148.38
+1.26%
HEALTHCARE · Cap: $289.19B
OWLT
Owlet Inc
$5.11
+3.23%
HEALTHCARE · Cap: $145.01M
Smart Verdict
WallStSmart Research — data-driven comparison
Novartis AG ADR generates 52747% more annual revenue ($56.58B vs $107.06M). NVS leads profitability with a 23.9% profit margin vs -43.0%. NVS earns a higher WallStSmart Score of 49/100 (D+).
NVS
Hold49
out of 100
Grade: D+
OWLT
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-62.6%
Fair Value
$91.58
Current Price
$148.38
$56.80 premium
Intrinsic value data unavailable for OWLT.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 35 in profit
Strong operational efficiency at 30.5%
Keeps 24 of every $100 in revenue as profit
Generating 2.9B in free cash flow
No standout strengths identified
Areas to Watch
Grey zone — moderate risk
Elevated debt levels
Expensive relative to growth rate
Revenue declined 0.7%
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -526.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : NVS
The strongest argument for NVS centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 23.9% and operating margin at 30.5%.
Bull Case : OWLT
OWLT has a balanced fundamental profile.
Bear Case : NVS
The primary concerns for NVS are Altman Z-Score, Debt/Equity, PEG Ratio.
Bear Case : OWLT
The primary concerns for OWLT are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
NVS profiles as a declining stock while OWLT is a turnaround play — different risk/reward profiles.
OWLT carries more volatility with a beta of 1.86 — expect wider price swings.
OWLT is growing revenue faster at 6.4% — sustainability is the question.
NVS generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
NVS scores higher overall (49/100 vs 28/100), backed by strong 23.9% margins. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novartis AG ADR
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Visit Website →Owlet Inc
HEALTHCARE · MEDICAL DEVICES · USA
Owlet Inc. is a pioneering leader in infant health technology, focused on enhancing the safety and wellness of newborns through its innovative monitoring solutions. Its flagship product, the Owlet Smart Sock, utilizes advanced pulse oximetry to deliver real-time insights into heart rates and oxygen levels, allowing parents to access crucial health data via mobile devices. As demand for pediatric health monitoring continues to rise, Owlet is strategically positioned to expand its product portfolio and strengthen its market presence. The company's commitment to delivering actionable health information and improving pediatric care aligns closely with institutional investors' interests in the rapidly evolving landscape of health technology.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?